N V Chandrachoodamani
Chandrachoodamani started his capital market career in mid 2000s with Equity Intelligence India and then worked with several capital market Intermediaries in various roles over the last 15 years. Most of his career experience has been in equity research and PMS. Most recently, he was with MOAT, a PMS firm. He is a graduate in mathematics, a post graduate in finance, and holds a CFP certification. LinkedIn|Twitter
All Posts »
More like this
Nifty IT Stocks Rally: A price bounce or a sector turnaround?
PrimeInvestor Research Team
August 4, 2026
Read More »
Technical outlook: Promise in Consumer Durables, the grind continues in Nifty50
B Krishnakumar
August 3, 2026
Read More »
8 thoughts on “Prime Stocks update: Moving this biotech stock from <em>BUY</em> to a <em>HOLD</em>”
Hi, I have been following your stock recommendations, as part of long term investment why do Prime investor team churns the stock to sell within short term.
As per recommendations, stock is picked by investors, however it results to losses.
Before recommendations, it involves Thorough Fundamental checks as it is named under long-term portfolio.
It would be useful if you can provide us detailed view on stock pick and sell point.
When the stock prospects slip or our thesis on its growth does not pan out – what we look at is whether by holding on (the stock may do well in the very long term, possible), are we missing other opportunities to return better now. If the answer is yes, we do give sell calls. We are great believers of long-term investments but not holding a stock eternally when growth does not pan our as expected. thanks, Vidya
Thank you for quick fix and detailed explanation in your all posts.
Why don’t you people give stock / company name in the headline of the article, in this article you have not given the company name at all.
We don’t include the stock name in the title, as these reports are restricted to Growth subscribers only. We usually have the stock name within the report, we missed it this time. Apologies about that. We have already updated the report to have the stock name. – thanks, Bhavana
Can you please mention the name of the stock in the report for easy reference? I had to go through the first recommendation to understand which stock you were referring to.
Sorry about that, and thank yo for pointing it out. We have updated the post. – thanks, Bhavana
Thank you!
Comments are closed.